About Bright Green Corporation - Common Stock (BGXX)
Bright Green Corporation is a biotechnology company specializing in the cultivation and production of cannabis for medicinal and research purposes. The company focuses on advancing the science of cannabis by leveraging state-of-the-art cultivation techniques and cutting-edge research to deliver high-quality, compliant products. Bright Green aims to support the healthcare industry by providing access to safe and effective cannabis treatments while also exploring new applications in various therapeutic areas. The organization is committed to sustainable practices and adheres to stringent regulatory standards to ensure the integrity and efficacy of its offerings. Read More
FORT LAUDERDALE, FLORIDA, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC: BGXX) (“Bright Green” or the “Company”) announced that on February 24, 2025, on behalf of the Company, Lynn Stockwell has asked the court to approve the “RSA” Restructuring Security Agreement. The highlights of the RSA will provide new equity for the company to pay all creditors with approved claims in full, in addition the Company equity shareholders will retain their interests in the Company and are unimpaired with no dilution.
Bright Green Corporation addresses Nasdaq delisting, reinforces its commitment to shareholders, and outlines strategic partnerships and growth plans for the future.
RJD Green Inc. (OTC: RJDG) captured significant investor attention, leading to a substantial stock gain of 29.5% on June 5, 2024. The trading volume surged to nine times the average daily volume. The company announced that its business unit, Silex Holdings Inc., achieved its highest monthly revenue since its establishment in June 2006. In May, Silex Holdings, Inc., a division of RJD Green, recorded $865,730 in revenues and a net operating profit of $242,404 . For context, the average annual revenue from Silex over the past two years was $4,800,000, with May 2024 revenues accounting for 18.1% of the annual income in 2023.
